Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
McKinsey
Mallinckrodt
Johnson and Johnson
Colorcon

Last Updated: November 20, 2019

DrugPatentWatch Database Preview

Profile for Argentina Patent: 065439

See Plans and Pricing

« Back to Dashboard

US Patent Family Members and Drugs in Development for Argentina Patent: 065439

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
Related US Patent Drugname Estimated Expiration
  Start Trial Thymalfasin 2026-07-07
  Start Trial Thymalfasin 2026-07-07
  Start Trial Bavituximab 2026-07-07
  Start Trial SCY-635 2026-07-07
  Start Trial Thymalfasin 2026-07-07
  Start Trial Thymalfasin 2026-07-07
>Related US Patent >Drugname >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Colorcon
Express Scripts
Johnson and Johnson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.